NCT01278797View on ClinicalTrials.gov

Telmisartan and Amlodipine Versus Monocomponent Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

February 28, 2011

Conditions
Hypertension
Interventions
DRUG

Telmisartan/Amlodipine Combination Tablet

Combination Tablet

DRUG

Amlodipine Monocomponent

Active Comparator

Trial Locations (1)

Unknown

1235.41.0001 Boehringer Ingelheim Investigational Site, Toronto

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY